BioInformant announces key enhancements to its Biotechnology Email Lists that will allow life science companies even more power to reach the inbox of prospective customers, including Geographical Segmentation that will allow aggressive, country-specific marketing.
Previously, BioInformant offered targeted Biotechnology Email Lists broken down by Area of Research, including the following:
-Gene therapy Researchers
-Tissue Engineering Researchers
-DNA Damage Researchers
-Stem Cell Researchers
These lists allowed numerous clients, including major research supplier such as Invitrogen and R&D Systems, to effectively meet sales goals for units sold within specific product lines. They also were used effectively by promoters of professional conferences, to promote conferences about Stem Cell Research and Advances in Gene Therapy.
To further serve its clients, BioInformant announced that it is now able to segment its Biotechnology Email Lists by Geographic Location. BioInformant’s new email lists include:
-Central American Researchers
-South American Researchers
-Middle Eastern Researchers
-Australian / New Zealand Researchers
-United States Researchers
BioInformant believes availability of its new geographic selects will allow research supply companies to strategically build international sales through aggressive, country-specific marketing. It will also allow research suppliers to customize their marketing campaign messages to each region of interest.
For example, a recent BioInformant client recognized that Australia is the site of an enormous amount of Microbiology research, resulting from the Australian government supporting an on-going commitment to agricultural and veterinary biotechnology research. Specifically, the regional focus is on plant breeding and improved crop varieties (molecular markers, yield, resistance to diseases and pests, diagnostics), and improved productivity of livestock (microbial testing, biomedical diagnostics). This client used BioInformant’s Australian Mailing List to strategically promote its line of microbiology research products – including culture media, rapid test kits, stains, and reagents – to researchers throughout the Commonwealth of Australia. The result was a ROI of $ 55 dollars per $ 1 spent on its email marketing campaign, and a nearly 40% increase in annual sales to Australian researchers.
BioInformant was founded on the belief that technology has the potential to help early-stage companies survive in competitive business environments. Since then, management has recognized the potential for technology to improve return-on-investment for companies of all sizes, by promoting efficient operations. Today, BioInformant serves companies ranging from an eight person SBIR-funded start-up company to a pharmaceutical giant with a market cap of over 50 billion.
Our multi-disciplinary team of technology specialists, business analysts, and scientific experts have produced a variety of services that utilize internet technology to enable business leaders to understand their market, competitors, and customers. These services, leveraged with the personalized service we provide, help clients to invest in high return-on-investment projects and run profitable operations.
Given the current economic condition, it is important for Biotechnology Companies to sell their products into new markets. BioInformant’s new Biotechnology Mailing Lists segmented by Geographical Location support this approach.
For a complimentary Executive Summary of this report, visit: http://www.bioinformant.com/, email email@example.com, or call us at 703-859-7671.